MBX
MBX
US55287L1017
MBX Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.56B EUR
2.65B EUR
1.42B EUR
1.42B EUR
Enterprise Value
2.15B EUR
2.6B EUR
1.38B EUR
1.34B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-13.39x
--
--
--
Price to Sales
--
--
--
--
Price to Book
6.23x
6.46x
3.24x
3.84x
EV/Revenue
--
--
--
--
EV/EBITDA
-18.27x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.07%
-3.22%
-5.62%
-4.18%
ende